Compare CNNE & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNNE | VALN |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.5M | 536.9M |
| IPO Year | 2017 | 2021 |
| Metric | CNNE | VALN |
|---|---|---|
| Price | $13.94 | $5.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $20.25 | $15.50 |
| AVG Volume (30 Days) | ★ 433.8K | 47.7K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.47% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $499,700,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $93.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.37 | N/A |
| 52 Week Low | $10.46 | $5.06 |
| 52 Week High | $21.96 | $12.25 |
| Indicator | CNNE | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 49.54 |
| Support Level | $13.83 | $5.81 |
| Resistance Level | $16.41 | $6.53 |
| Average True Range (ATR) | 0.53 | 0.25 |
| MACD | -0.04 | 0.11 |
| Stochastic Oscillator | 58.48 | 49.31 |
Cannae Holdings Inc is an investment holding company that acquires and actively manages equity interests in operating businesses across various industries. The Company focuses on long-term ownership and seeks to create value by supporting the growth and operations of its portfolio companies through management expertise and strategic oversight. The Company operates through four reportable segments: Restaurant Group, which includes the operations of O'Charleys and 99 Restaurants; Alight, which represents its ownership interest in a technology-enabled human capital and employee benefits solutions provider; Black Knight Football Club (BKFC), which holds interests in professional football clubs; and JANA, which represents its investment in an investment management firm.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.